Importantly, there was no correlation between glutamine levels and ataxia scores in symptomatic patients or pathology scores in symptomatic SCA1 mutant mice, suggesting that the accumulation of this specific metabolite was a biochemical marker of the pre-symptomatic disease state [74, 76]. The gene discussed is ATXN1; the disease is cerebellar ataxia.